University of Rochester Medical Center PPDS — Rochester, New York

University of Rochester Medical Center PPDS is a clinical research site located in Rochester, New York, United States 14642-0001.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Rochester Medical Center PPDS has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Crohn's Disease (CD).

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, Lakefront Biotherapeutics NV, Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in New York · View every site in Rochester

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester Medical Center PPDS?

University of Rochester Medical Center PPDS has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester Medical Center PPDS conducted?

University of Rochester Medical Center PPDS has 7 clinical trials on record, with 3 currently active. Their work covers Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Crohn's Disease (CD).

Is University of Rochester Medical Center PPDS accredited by Crixeo Clinical Trials?

University of Rochester Medical Center PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester Medical Center PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.